Oxycodone/Naloxone Krka (Naloxone Hydrochloride, Oxycodone Hydrochloride)

Oxycodone, the active ingredient in Oxycodone/Naloxone Krka, is a opioid analgesic presented as a combination tablet for oral use. It treats moderate to severe pain in adult patients when an opioid is required. Naloxone, the second active ingredient, is an opioid antagonist included to mitigate opioid‑induced constipation.

GNH USA supplies Oxycodone/Naloxone Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Oxycodone/Naloxone Krka is used in the management of pain conditions that involve opioid‑mediated pathways. - Chronic non‑cancer pain: provides analgesia while reducing constipation risk. - Cancer‑related pain: offers strong opioid relief with built‑in bowel‑function protection. - Post‑operative pain: delivers effective postoperative analgesia with a lower incidence of opioid‑induced bowel dysfunction.

Adverse reactions may occur with any opioid‑containing product.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Constipation: reduced bowel motility, though less frequent than with oxycodone alone. - Dizziness: light‑headed sensation, especially on standing. - Somnolence: increased sleepiness or fatigue. - Dry mouth: reduced salivation. - Headache: mild to moderate cranial pain.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Opioid dependence or withdrawal: signs of addiction or abrupt cessation symptoms. - Hepatic impairment: elevated liver enzymes or liver injury. - Seizures: rare neurologic events.

When prescribing Oxycodone/Naloxone Krka, clinicians should consider several safety measures. - Assess pain severity: confirm that opioid therapy is appropriate. - Monitor for respiratory depression: especially during initiation or dose changes. - Evaluate bowel function: ensure the naloxone component is effective. - Review concomitant CNS depressants: avoid additive sedation. - Adjust for renal/hepatic impairment: dose may need modification. - Store at ambient temperature: keep below 25°C in the original container, protected from moisture.

Oxycodone/Naloxone Krka can interact with several medication classes.

Major Interactions (Avoid): - Benzodiazepines: combined use can cause profound respiratory depression. - CNS depressants: additive sedation and lowered consciousness. - MAO inhibitors: risk of severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs/SNRIs): may increase serotonin levels. - Anticholinergics: can exacerbate constipation. - CYP3A4 inhibitors (e.g., ketoconazole): may raise oxycodone plasma concentrations.